Quantinno Capital Management LP Buys 79,664 Shares of Amdocs Limited $DOX

Quantinno Capital Management LP lifted its stake in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 58.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 215,907 shares of the technology company’s stock after acquiring an additional 79,664 shares during the period. Quantinno Capital Management LP’s holdings in Amdocs were worth $14,090,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of DOX. Scotia Capital Inc. grew its holdings in Amdocs by 3.5% in the third quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after purchasing an additional 145 shares during the period. WealthCollab LLC grew its stake in shares of Amdocs by 94.5% in the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after buying an additional 173 shares during the period. Blair William & Co. IL grew its stake in shares of Amdocs by 5.5% in the 3rd quarter. Blair William & Co. IL now owns 3,393 shares of the technology company’s stock valued at $278,000 after buying an additional 177 shares during the period. Mercer Global Advisors Inc. ADV increased its position in Amdocs by 2.2% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 9,634 shares of the technology company’s stock valued at $790,000 after buying an additional 204 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its stake in Amdocs by 3.5% during the 1st quarter. Sequoia Financial Advisors LLC now owns 6,443 shares of the technology company’s stock worth $420,000 after buying an additional 218 shares during the period. 92.02% of the stock is owned by institutional investors.

Amdocs Stock Performance

Shares of Amdocs stock opened at $55.72 on Monday. The stock has a fifty day simple moving average of $54.92 and a 200 day simple moving average of $64.09. Amdocs Limited has a 12-month low of $49.74 and a 12-month high of $90.29. The company has a market capitalization of $6.01 billion, a P/E ratio of 11.14, a price-to-earnings-growth ratio of 0.97 and a beta of 0.40. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings data on Thursday, May 14th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The firm had revenue of $1.17 billion for the quarter, compared to the consensus estimate of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The business’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.78 EPS. On average, sell-side analysts anticipate that Amdocs Limited will post 6.56 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were given a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date of this dividend was Tuesday, June 30th. Amdocs’s dividend payout ratio is presently 45.60%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Cfra cut Amdocs to a “sell” rating in a research note on Thursday, May 14th. Weiss Ratings reissued a “hold (c-)” rating on shares of Amdocs in a research report on Friday, May 8th. Stifel Nicolaus decreased their price target on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a report on Sunday, July 5th. Finally, KeyCorp started coverage on shares of Amdocs in a research report on Monday, June 29th. They set a “sector weight” rating for the company. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Amdocs has an average rating of “Hold” and an average target price of $86.67.

View Our Latest Stock Report on Amdocs

About Amdocs

(Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Recommended Stories

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.